{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T03:01:18Z","timestamp":1774666878440,"version":"3.50.1"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005629","name":"Viropharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005629","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006396","name":"Alexion Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006396","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["13\/08135-2"],"award-info":[{"award-number":["13\/08135-2"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01AI068730"],"award-info":[{"award-number":["P01AI068730"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.clim.2020.108598","type":"journal-article","created":{"date-parts":[[2020,9,19]],"date-time":"2020-09-19T11:16:13Z","timestamp":1600514173000},"page":"108598","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":207,"special_numbering":"C","title":["Complement C3 vs C5 inhibition in severe COVID-19: Early clinical findings reveal differential biological efficacy"],"prefix":"10.1016","volume":"220","author":[{"given":"Dimitrios C.","family":"Mastellos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno G.P.","family":"Pires da Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benedito A.L.","family":"Fonseca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natasha P.","family":"Fonseca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Auxiliadora-Martins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Mastaglio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annalisa","family":"Ruggeri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Sironi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Radermacher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akrivi","family":"Chrysanthopoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panagiotis","family":"Skendros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantinos","family":"Ritis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilenia","family":"Manfra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simona","family":"Iacobelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Huber-Lang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Despina","family":"Yancopoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. Sander","family":"Connolly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cecilia","family":"Garlanda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio","family":"Ciceri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio M.","family":"Risitano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodrigo T.","family":"Calado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John D.","family":"Lambris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10223","key":"10.1016\/j.clim.2020.108598_bb0005","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet."},{"issue":"7","key":"10.1016\/j.clim.2020.108598_bb0010","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/s41591-020-0968-3","article-title":"Extrapulmonary manifestations of COVID-19","volume":"26","author":"Gupta","year":"2020","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.clim.2020.108598_bb0015","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1056\/NEJMoa2015432","article-title":"Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19","volume":"383","author":"Ackermann","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2020.108598_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trsl.2020.04.007","article-title":"Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases","volume":"220","author":"Magro","year":"2020","journal-title":"Transl. Res."},{"key":"10.1016\/j.clim.2020.108598_bb0025","first-page":"1","article-title":"Complement as a target in COVID-19?","volume":"2020","author":"Risitano","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.clim.2020.108598_bb0030","first-page":"1","article-title":"Emerging evidence of a COVID-19 thrombotic syndrome has treatment implications","author":"Merrill","year":"2020","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.clim.2020.108598_bb0035","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1172\/jci.insight.140711","article-title":"The complement system in COVID-19: friend and foe?","volume":"5","author":"Java","year":"2020","journal-title":"JCI Insight."},{"key":"10.1016\/j.clim.2020.108598_bb0040","doi-asserted-by":"crossref","first-page":"108448","DOI":"10.1016\/j.clim.2020.108448","article-title":"COVID-19: immunology and treatment options","volume":"215","author":"Felsenstein","year":"2020","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2020.108598_bb0045","doi-asserted-by":"crossref","first-page":"108518","DOI":"10.1016\/j.clim.2020.108518","article-title":"Imatinib for COVID-19: a case report","volume":"218","author":"Morales-Ortega","year":"2020","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2020.108598_bb0050","doi-asserted-by":"crossref","first-page":"108490","DOI":"10.1016\/j.clim.2020.108490","article-title":"Treating COVID-19 with colchicine in community healthcare setting","volume":"217","author":"Della-Torre","year":"2020","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2020.108598_bb0055","doi-asserted-by":"crossref","first-page":"108544","DOI":"10.1016\/j.clim.2020.108544","article-title":"Therapeutic blockade of inflammation in severe COVID-19 infection with intravenous N-acetylcysteine","volume":"219","author":"Ibrahim","year":"2020","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2020.108598_bb0060","doi-asserted-by":"crossref","DOI":"10.1172\/JCI141374","article-title":"Complement and tissue factor-enriched neutrophil extracellular traps are key drivers in COVID-19 immunothrombosis","author":"Skendros","year":"2020","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clim.2020.108598_bb0065","first-page":"1","article-title":"Immune complement and coagulation dysfunction in adverse outcomes of SARS-CoV-2 infection","author":"Ramlall","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.clim.2020.108598_bb0070","first-page":"1","article-title":"Association of COVID-19 inflammation with activation of the C5a-C5aR1 axis","author":"Carvelli","year":"2020","journal-title":"Nature."},{"key":"10.1016\/j.clim.2020.108598_bb0075","article-title":"Highly pathogenic coronavirus N protein aggravates lung injury by MASP-2-mediated complement over-activation","author":"Gao","year":"2020","journal-title":"medRxiv."},{"issue":"1","key":"10.1016\/j.clim.2020.108598_bb0080","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jaci.2020.05.006","article-title":"Complement activation in patients with COVID-19: a novel therapeutic target","volume":"146","author":"Cugno","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"issue":"5","key":"10.1016\/j.clim.2020.108598_bb0085","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01753-18","article-title":"Complement activation contributes to severe acute respiratory syndrome coronavirus pathogenesis","volume":"9","author":"Gralinski","year":"2018","journal-title":"MBio"},{"issue":"4","key":"10.1016\/j.clim.2020.108598_bb0090","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/ajh.25016","article-title":"Toward complement inhibition 2.0: Next generation anticomplement agents for paroxysmal nocturnal hemoglobinuria","volume":"93","author":"Risitano","year":"2018","journal-title":"Am.J.Hematol."},{"issue":"9","key":"10.1016\/j.clim.2020.108598_bb0095","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/s41573-019-0031-6","article-title":"Clinical promise of next-generation complement therapeutics","volume":"18","author":"Mastellos","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"issue":"13","key":"10.1016\/j.clim.2020.108598_bb0100","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1001\/jama.2020.2648","article-title":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention","volume":"323","author":"Wu","year":"2020","journal-title":"JAMA - J. Am. Med. Assoc."},{"issue":"5","key":"10.1016\/j.clim.2020.108598_bb0105","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1128\/CVI.00486-06","article-title":"Use of serum or buffer-changed EDTA-plasma in a rapid, inexpensive, and easy-to-perform hemolytic complement assay for differential diagnosis of systemic lupus erythematosus and monitoring of patients with the disease","volume":"14","author":"Ekdahl","year":"2007","journal-title":"Clin. Vaccine Immunol."},{"issue":"10","key":"10.1016\/j.clim.2020.108598_bb0110","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.2337\/diabetes.48.10.1907","article-title":"Incompatibility between human blood and isolated islets of langerhans: a finding with implications for clinical intraportal islet transplantation?","volume":"48","author":"Bennet","year":"1999","journal-title":"Diabetes."},{"key":"10.1016\/j.clim.2020.108598_bb0115","first-page":"1041","article-title":"Method development and validation for the quantitation of the complement inhibitor Cp40 in human and cynomolgus monkey plasma by UPLC-ESI-MS","author":"Primikyri","year":"2017","journal-title":"J.Chromatogr.B Anal. Sci."},{"issue":"6","key":"10.1016\/j.clim.2020.108598_bb0120","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nm.1959","article-title":"Netting neutrophils in autoimmune small-vessel vasculitis","volume":"15","author":"Kessenbrock","year":"2009","journal-title":"Nat. Med."},{"issue":"9","key":"10.1016\/j.clim.2020.108598_bb0125","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S2352-3026(20)30217-9","article-title":"Haematological characteristics and risk factors in the classification and prognosis evaluation of COVID-19: a retrospective cohort study","volume":"7","author":"Liao","year":"2020","journal-title":"Lancet. Haematol."},{"key":"10.1016\/j.clim.2020.108598_bb0130","article-title":"Early predictors of clinical outcomes of COVID-19 outbreak in Milan","volume":"217","author":"Ciceri","year":"2020","journal-title":"Italy. Clin. Immunol."},{"key":"10.1016\/j.clim.2020.108598_bb0135","article-title":"Dysregulated adaptive immune response contributes to severe COVID-19","volume":"1","author":"Yu","year":"2020","journal-title":"Cell Res."},{"issue":"23","key":"10.1016\/j.clim.2020.108598_bb0140","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1182\/blood.2020006000","article-title":"COVID-19 and its implications for thrombosis and anticoagulation","volume":"135","author":"Connors","year":"2020","journal-title":"Blood."},{"key":"10.1016\/j.clim.2020.108598_bb0145","article-title":"Complement C5 inhibition in patients with COVID-19 - a promising target?","author":"Peffault De Latour","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.clim.2020.108598_bb0150","article-title":"The first case of COVID-19 treated with the complement C3 inhibitor AMY-101","volume":"108450","author":"Mastaglio","year":"2020","journal-title":"Clin. Immunol."},{"issue":"7","key":"10.1016\/j.clim.2020.108598_bb0155","first-page":"4040","article-title":"Eculizumab treatment in patients with COVID-19: preliminary results from real life ASL Napoli 2 Nord experience","volume":"24","author":"Diurno","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.clim.2020.108598_bb0160","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.00857","article-title":"Combination of Ruxolitinib and Eculizumab for treatment of severe SARS-CoV-2-related acute respiratory distress syndrome: a controlled study","volume":"11","author":"Giudice","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"5","key":"10.1016\/j.clim.2020.108598_bb0165","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.cell.2020.04.026","article-title":"Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19","volume":"181","author":"Blanco-Melo","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.clim.2020.108598_bb0170","series-title":"SARS-CoV2 Drives JAK1\/2-Dependent Local and Systemic Complement Hyper-Activation","author":"Yan","year":"2020"},{"issue":"2","key":"10.1016\/j.clim.2020.108598_bb0175","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s005990050029","article-title":"Methylprednisolone-induced neutrophil leukocytosis down-modulation of neutrophil L-selectin and mac-1 expression and induction of granulocyte-colony stimulating factor","volume":"28","author":"Crockard","year":"1998","journal-title":"Int. J. Clin. Lab. Res."},{"issue":"11","key":"10.1016\/j.clim.2020.108598_bb0180","article-title":"Neutrophil extracellular traps in COVID-19","volume":"5","author":"Zuo","year":"2020","journal-title":"JCI Insight."},{"issue":"1","key":"10.1016\/j.clim.2020.108598_bb0185","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41423-018-0024-0","article-title":"NETosis, complement, and coagulation: a triangular relationship","volume":"16","author":"de Bont","year":"2019","journal-title":"Cell. Mol. Immunol."},{"issue":"1","key":"10.1016\/j.clim.2020.108598_bb0190","first-page":"1","article-title":"Plasma neutrophil extracellular trap level is modified by disease severity and inhaled corticosteroids in chronic inflammatory lung diseases","volume":"10","author":"G\u00e1l","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.clim.2020.108598_bb0195","first-page":"1","article-title":"T cell responses in patients with COVID-19","author":"Chen","year":"2020","journal-title":"Nat. Rev. Immunol."},{"issue":"9","key":"10.1016\/j.clim.2020.108598_bb0200","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1326442","article-title":"Local endothelial complement activation reverses endothelial quiescence, enabling t-cell homing, and tumor control during t-cell immunotherapy","volume":"6","author":"Facciabene","year":"2017","journal-title":"Oncoimmunology."},{"issue":"16","key":"10.1016\/j.clim.2020.108598_bb0205","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1161\/CIRCULATIONAHA.118.034600","article-title":"Functional relevance of the anaphylatoxin receptor C3aR for platelet function and arterial thrombus formation marks an intersection point between innate immunity and thrombosis","volume":"138","author":"Sauter","year":"2018","journal-title":"Circulation."},{"issue":"1","key":"10.1016\/j.clim.2020.108598_bb0210","doi-asserted-by":"crossref","first-page":"172","DOI":"10.4049\/jimmunol.1100491","article-title":"Alternative pathway activation of complement by Shiga toxin promotes exuberant C3a formation that triggers microvascular thrombosis","volume":"187","author":"Morigi","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2020.108598_bb0215","article-title":"Dexamethasone in Hospitalized Patients with Covid-19 \u2014 Preliminary Report","author":"Horby","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"22","key":"10.1016\/j.clim.2020.108598_bb0220","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1161\/CIRCULATIONAHA.120.047419","article-title":"Will Complement Inhibition Be the New Target in Treating COVID-19 Related Systemic Thrombosis?","volume":"141","author":"Campbell","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.clim.2020.108598_bb0225","article-title":"Erythrocytes Reveal Complement Activation in Patients with COVID-19","author":"Lam","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.clim.2020.108598_bb0230","article-title":"Anti-complement C5 therapy with eculizumab in three cases of critical COVID-19","volume":"108555","author":"Laurence","year":"2020","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2020.108598_bb0235","unstructured":"Roche'\u2019s Actemra Misses the Mark in Phase III COVID-19 Associated Pneumonia Study | BioSpace."},{"key":"10.1016\/j.clim.2020.108598_bb6060","doi-asserted-by":"crossref","unstructured":"Ghebrehiwet B, Peerschke EI. Complement and coagulation: key triggers of COVID-19-induced multiorgan pathology. J Clin Invest. 2020 Sep 14:142780. doi: 10.1172\/JCI142780. Online ahead of print.","DOI":"10.1172\/JCI142780"},{"issue":"6","key":"10.1016\/j.clim.2020.108598_bb6035","doi-asserted-by":"crossref","first-page":"e227","DOI":"10.1111\/bjh.16783","article-title":"Severe COVID-19 infection and thrombotic microangiopathy: success does not come easily","volume":"189","author":"Gavriilaki","year":"2020","journal-title":"Br J Haematol"}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661620307580?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661620307580?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:01:48Z","timestamp":1761494508000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661620307580"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":49,"alternative-id":["S1521661620307580"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2020.108598","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.08.17.20174474","asserted-by":"object"}]},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Complement C3 vs C5 inhibition in severe COVID-19: Early clinical findings reveal differential biological efficacy","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2020.108598","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108598"}}